Skip to content

Nasdaq · CIK 0000748592

ERNA Ernexa Therapeutics Inc.

Insider trading from SEC Form 4. Last filing 41 d ago.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company

Signals

Open-market buys and sells at Ernexa Therapeutics Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
47ModerateCharles Cherington
owner
buy
$2.2M
21,241,163 shares
+104%-
29WeakCharles Cherington
owner
buy
$394k
3,768,397 shares
+23%-

Transactions

The last 43 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 31, 2026Peter Cicala
director
AGrant or award
Stock Option (Right to buy)derivative
+5,943$0.00$05,94341 d ago
Aug 31, 2026Sanjeev Luther
President and CEO
AGrant or award
Stock Option (right to buy)derivative
+118,848$0.00$0118,84841 d ago
Aug 31, 2026Elena Ratner
director
AGrant or award
Stock Option (Right to buy)derivative
+5,944$0.00$05,94441 d ago
Aug 31, 2026William A. Wexler
director
AGrant or award
Stock Option (Right to buy)derivative
+5,943$0.00$05,94341 d ago
Aug 31, 2026David Polinsky
director
AGrant or award
Stock Option (Right to buy)derivative
+5,083$0.00$05,08341 d ago
Aug 31, 2026James Arthur Bristol
director
AGrant or award
Stock Option (Right to buy)derivative
+8,320$0.00$08,32041 d ago
Aug 31, 2026James Arthur Bristol
director
AGrant or award
Stock Option (Right to buy)derivative
+5,083$0.00$05,08341 d ago
Aug 31, 2026Peter Cicala
director
AGrant or award
Stock Option (Right to buy)derivative
+5,083$0.00$05,08341 d ago
Jun 9, 2025Charles Cherington
owner
POpen-market purchase
Common Stock
+21,241,163$0.10$2.2M41,659,743Jun 11, 2025
Sep 24, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+261,756--818,221May 7, 2025
Sep 24, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+4,768,783--5,587,004May 7, 2025
Sep 24, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+1,237,762--6,824,766May 7, 2025
Sep 24, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+5,420,823--12,245,589May 7, 2025
Sep 24, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+1,562,988--13,808,577May 7, 2025
Sep 24, 2024Charles Cherington
owner
SOpen-market sale
12.0% Senior Convertible Notes due December 12, 2028derivative
---0May 7, 2025
Sep 24, 2024Charles Cherington
owner
SOpen-market sale
6.0% Senior Convertible Promissory Notes due 2028derivative
---0May 7, 2025
Sep 24, 2024Charles Cherington
owner
SOpen-market sale
Warrants (right to buy)derivative
-523,512--0May 7, 2025
Sep 24, 2024Charles Cherington
owner
SOpen-market sale
Warrants (right to buy)derivative
-2,475,524--0May 7, 2025
Sep 24, 2024Charles Cherington
owner
SOpen-market sale
Warrants (right to buy)derivative
-3,125,976--0May 7, 2025
Apr 2, 2025Charles Cherington
owner
POpen-market purchase
Common Stock
+3,768,397$0.10$394k20,401,602Apr 4, 2025
Feb 7, 2025Sandra M Gurrola
Sr. VP of Finance
AGrant or award
Stock Option (Right to buy)derivative
+150,000$0.00$0150,000Feb 10, 2025
Feb 7, 2025James Arthur Bristol
director
AGrant or award
Stock Option (Right to buy)derivative
+72,074$0.00$072,074Feb 10, 2025
Feb 7, 2025Peter Cicala
director
AGrant or award
Stock Option (Right to buy)derivative
+51,485$0.00$051,485Feb 10, 2025
Feb 7, 2025William A. Wexler
director
AGrant or award
Stock Option (right to buy)derivative
+124,533$0.00$0124,533Feb 10, 2025
Feb 7, 2025Sanjeev Luther
President & CEO
AGrant or award
Stock Option (right to buy)derivative
+1,123,350$0.00$01,123,350Feb 10, 2025
Jan 13, 2025Elena Ratner
director
AGrant or award
Stock Option (Right to buy)derivative
+140,078$0.00$0140,078Jan 14, 2025
Oct 29, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+261,756--818,221Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+4,768,783--5,587,004Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+1,237,762--6,824,766Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+5,420,823--12,245,589Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
POpen-market purchase
Common Stock
+1,562,988--13,808,577Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
CConversion
Common Stock
+2,819,546$0.50$1.4M16,628,123Nov 5, 2024
Sep 23, 2024Charles Cherington
owner
POpen-market purchase
6.0% Senior Convertible Promissory Notes due 2028derivative
----Nov 5, 2024
Sep 23, 2024Charles Cherington
owner
POpen-market purchase
Warrants (right to buy)derivative
+83,916--2,391,608Nov 5, 2024
Sep 23, 2024Charles Cherington
owner
POpen-market purchase
6.0% Senior Convertible Promissory Notes due 2028derivative
----Nov 5, 2024
Sep 23, 2024Charles Cherington
owner
POpen-market purchase
Warrants (right to buy)derivative
+83,916--2,475,524Nov 5, 2024
Sep 24, 2024Charles Cherington
owner
POpen-market purchase
12.0% Senior Convertible Notes due September 24, 2025derivative
-$1,368,626.00--Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
CConversion
12.0% Senior Convertible Notes due September 24, 2025derivative
-$0.00-0Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
SOpen-market sale
12.0% Senior Convertible Notes due December 12, 2028derivative
---0Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
SOpen-market sale
6.0% Senior Convertible Promissory Notes due 2028derivative
---0Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
SOpen-market sale
Warrants (right to buy)derivative
-523,512--0Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
SOpen-market sale
Warrants (right to buy)derivative
-2,475,524--0Nov 5, 2024
Oct 29, 2024Charles Cherington
owner
SOpen-market sale
Warrants (right to buy)derivative
-3,125,976--0Nov 5, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ERNA insider trading: Ernexa Therapeutics Inc. | InsiderTell